Skip to content
Wearables & measurementResearch article3 min read

Apple Watch heart rate variability changed before and during COVID-19 in health care workers

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Use of Physiological Data From a Wearable Device to Identify SARS-CoV-2 Infection and Symptoms and Predict COVID-19 Diagnosis: Observational Study. · Journal of medical Internet research · 2021 · Original paper ↗

Key takeaway

In health care workers wearing an Apple Watch, the circadian amplitude of an HRV measure (SDNN) differed between people with and without COVID-19 (P=.006) and in the 7 days around diagnosis versus uninfected periods (P=.01). The abstract gives no participant numbers or accuracy, so its value as an individual warning is unproven.

Study design

Research article

Reading basis

Published abstract

Reading focus

Design & applicability

The research question

Infection can alter the autonomic nervous system, which shows up as changes in heart rate variability (HRV), sometimes before symptoms are clinically recognized. The authors tested whether HRV from a commercial smartwatch could identify COVID-19 and its symptoms, and whether changes appear ahead of diagnosis.

Who and how

Prospective observational study of health care workers in the Mount Sinai Health System using the custom Warrior Watch Study app on their smartphones. Participants wore an Apple Watch throughout follow-up, which measured HRV, and completed daily surveys about infection and symptoms. A mixed-effect cosinor model assessed the circadian pattern of SDNN (the standard deviation of the interbeat interval of normal sinus beats), comparing infected with uninfected people and infected with uninfected time periods. The abstract does not report the number of participants.

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    The mean amplitude of the daily (circadian) pattern of SDNN differed between people with and without COVID-19 (P=.006).
  2. 2
    The mean amplitude differed in the 7 days before and the 7 days after a COVID-19 diagnosis compared with uninfected periods (P=.01).
  3. 3
    The mean and amplitude of the SDNN pattern changed on the first day of reporting a COVID-19-related symptom compared with all other symptom-free days (P=.01).
  4. 4
    The authors conclude that HRV changes were seen before diagnosis by nasal swab PCR testing.

Limits & uncertainty

  1. 1
    The abstract reports no participant numbers, effect sizes or direction of change, so the size and practical meaning of the differences are unclear.
  2. 2
    Results are group-level P values; they do not give sensitivity, specificity or false-alarm rates for flagging infection in one person.
  3. 3
    Participants were health care workers in one health system, who may differ from the general public in exposure, stress and sleep.
  4. 4
    Many things besides infection alter HRV, such as sleep loss, alcohol, stress and training, so the changes are not specific to COVID-19.

What to take from it

A smartwatch HRV pattern may shift around the time of infection, which is interesting, but it cannot tell you that you have COVID-19. If you feel unwell or are exposed, use a test and follow medical advice rather than relying on a watch.

Reading your own data

Overnight HRV trends from a watch can show when your body is under strain. Use the same device and wear it the same way, and judge deviations from your own multi-week baseline rather than a single night; a sustained dip along with symptoms is a reason to rest and test, not a diagnosis.

How to read this evidence

The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Background

Changes in autonomic nervous system function, characterized by heart rate variability (HRV), have been associated with infection and observed prior to its clinical identification.

Objective

We performed an evaluation of HRV collected by a wearable device to identify and predict COVID-19 and its related symptoms.

Methods

Health care workers in the Mount Sinai Health System were prospectively followed in an ongoing observational study using the custom Warrior Watch Study app, which was downloaded to their smartphones. Participants wore an Apple Watch for the duration of the study, measuring HRV throughout the follow-up period. Surveys assessing infection and symptom-related questions were obtained daily.

Results

Using a mixed-effect cosinor model, the mean amplitude of the circadian pattern of the standard deviation of the interbeat interval of normal sinus beats (SDNN), an HRV metric, differed between subjects with and without COVID-19 (P=.006). The mean amplitude of this circadian pattern differed between individuals during the 7 days before and the 7 days after a COVID-19 diagnosis compared to this metric during uninfected time periods (P=.01). Significant changes in the mean and amplitude of the circadian pattern of the SDNN was observed between the first day of reporting a COVID-19-related symptom compared to all other symptom-free days (P=.01).

Conclusions

Longitudinally collected HRV metrics from a commonly worn commercial wearable device (Apple Watch) can predict the diagnosis of COVID-19 and identify COVID-19-related symptoms. Prior to the diagnosis of COVID-19 by nasal swab polymerase chain reaction testing, significant changes in HRV were observed, demonstrating the predictive ability of this metric to identify COVID-19 infection.

Sources & attribution

Use of Physiological Data From a Wearable Device to Identify SARS-CoV-2 Infection and Symptoms and Predict COVID-19 Diagnosis: Observational Study.

Hirten RP, Danieletto M, Tomalin L, Choi KH, Zweig M, Golden E, Kaur S, Helmus D, Biello A, Pyzik R, Charney A, Miotto R, Glicksberg BS, Levin M, Nabeel I, Aberg J, Reich D, Charney D, Bottinger EP, Keefer L, Suarez-Farinas M, Nadkarni GN, Fayad ZA.

Journal of medical Internet research · 2021-02-22

DOI: 10.2196/26107 ↗PubMed · 33529156 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Cohort study

Activity–stroke and heart attack curves differ by accelerometer processing method

Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.

Preventive Medicine

In-depth explainersRead study →
·Validation study/review

Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven

A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.

Forensic Science International

In-depth explainersRead study →
·Overview of reviews

Activity trackers: about 1,800 more steps a day, but small effects on other outcomes

An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.

The Lancet Digital Health

In-depth explainersRead study →
·Validation study/review

Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages

In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.

Sleep

In-depth explainersRead study →
Wearables & measurement →